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Abstract
The pathophysiology of hypoglycaemia in children with acute falciparum malaria, a frequent and serious 
complication, is unknown due to absence of data on glucose kinetics. We investigated the correlation be­
tween basal glucose production and plasma glucose concentration in 20 children (8 girls) with acute, un­
complicated falciparum malaria by infusion of [6,6-2H2]glucose. Median plasma glucose concentration was
4-5 (range 2-1—6-5) mmol/L and median glucose production 5*0 (range 4*1-84) mg/kg/min. There was a 
positive correlation between basal glucose production and plasma glucose concentration (r=0*53, P = 0 ’016). 
There was no correlation between the rate of glucose production and the plasma concentrations of alanine, 
lactate, counter-regulatory hormones or cytokines. It was concluded that, in children with acute uncompli­
cated falciparum malaria, endogenous glucose production is an important determinant of plasma glucose 
concentration, contrary to previous findings in adults with malaria, in whom peripheral uptake seems to be 
more important than glucose production in determining plasma glucose concentration.
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Introduction
Hyperglycaemia is a frequent finding in acute infec­
tions. Acute falciparum malaria is a peculiar infectious 
disease with respect to glucose metabolism as hypogly­
caemia instead of hyperglycaemia is a common compli­
cation, especially in children and pregnant women 
(L ooareesuw an  et a l y 1985; WHITE et aU  1987). Its in­
cidence in children with acute falciparum malaria is 
13'2% in Kilifi, Kenya, and it is associated with a much 
increased risk of death (M a rsh  et al.y 1995).
Hypoglycaemia is caused by inhibition of glucose pro­
duction and/or stimulation of glucose disposal. Basal 
glucose production in falciparum malaria has been meas­
ured only in adults, with plasma glucose concentrations 
above 3 mmol/L. In adults with complicated malaria, 
and in pregnant patients with uncomplicated malaria, 
average glucose production was increased during acute 
falciparum malaria compared to convalescence ( D avis et 
al., 1993, 1994). In non-pregnant patients there was an 
inverse correlation between glucose production and 
plasma glucose concentration (DAVIS et a/., 1993). The 
authors concluded that facilitated peripheral uptake (by 
the host and/or the parasite) was the factor most decisive 
in determining plasma glucose concentration in these 
adults.
There are no data available on glucose production 
during falciparum malaria in children* although globally 
children are by far the largest group at risk for the devel­
opment of hypoglycaemia (W h it e  et a l 3 1987; M a r sh  et 
al., 1995). The first objective of this study was therefore 
the measurement of basal glucose production in children 
with acute falciparum malaria by primed, continuous in­
fusion of [6,6- H2]glucose. We studied only those chil­
dren with plasma glucose concentrations ^2*2 mmol/L, 
because lower blood glucose levels would have necessi­
tated intravenous glucose infusion. Theoretically, low 
levels of gluconeogenic precursors and counter-regula­
tory hormones and high levels of cytokines may be im­
plicated in the induction of hypoglycaemia. The second 
objective was therefore the evaluation of the relation be­
tween the rate of basal glucose production and these fac­
tors.
Address for correspondence: Dr Evelien Dekker, Metabolism 
Unit, Department of Internal Medicine (F4-222), Academic 
Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The 
Netherlands; phone -1-31 20 566 2663, fax +31 20 691 9658.
Methods
Subjects
All children admitted to Kilifi District Hospital in 
Kenya with a primary diagnosis of malaria during the 
study period of 6 weeks were considered for inclusion in 
the study, Inclusion criteria were acute falciparum ma­
laria, age between 2 and 10 years, and a fasting period of 
at least 4 h. Exclusion criteria were admission plasma 
glucose concentration <2*2 mmol/L, complicated ma­
laria according to the World Health Organization crite­
ria (WHO, 1986) (because clinical practice dictates con­
stant glucose infusion in all such patients), treatment 
with quinine (quinine stimulates insulin secrection by 
the pancreas; H e n q u in  et al., 1975), concomitant infec­
tious disease, severe malnutrition, and severe chronic di­
arrhoea (which may induce hypoglycaemia in child­
hood; B e n n ish  etaly  1990). Witnessed informed consent 
was obtained from the accompanying parent or guard­
ian. The study protocol was approved by the Kenya Na­
tional Ethical Committee.
Study design
Patients were recruited immediately after laboratory 
confirmation of the clinical diagnosis and exclusion of 
quinine use by a quinine ‘dipstick’ test (SlLAMUT et aL> 
1995). Each patient was weighed and treatment with 
Fansidar®, in some cases combined with chloroquine, 
was given. An intravenous cannula was introduced in a 
forearm vein for isotope infusion. A second cannula for 
blood sampling was introduced into a suitable vein of 
the contralateral arm. The catheters were kept patent by 
a slow saline drip.
After obtaining a baseline blood sample for determi­
nation of background isotope enrichment, plasma glu­
cose, plasma cytokine concentrations and basal haemato- 
logical and biochemical tests, a primed (5*4 mg/kg), 
continuous (60 ^ig/kg/min) infusion of [6 ,6 -2H 2]glucose 
(99%, Isotec Inc., Miamisburg, Ohio, USA), dissolved in 
sterile isotonic saline and sterilized by passage through a 
Millipore™ filter (size 0-2 |±m; Minisart, Sartorius AG, 
Gottingen, Germany), was administered by a motor 
driven, calibrated syringe pump (Perfusor Secura F T "1, 
Braun AG, Melsungen, Germany). The rate of [6,6- 
2H2]glucose infusion was calculated from the measured 
concentration of glucose in the infusate. The time at the 
start of the infusion was set at t —0 .
After 90 min of [6 ,6-2H2]glucose infusion for equili­
bration, 3 blood samples were collected at intervals of 15
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min for determination of plasma glucose concentration 
and [6 ,6-2H 2]glucose enrichment. Blood samples for the 
measurement of concentrations of insulin, counter-regu­
latory hormones, alanine and lactate were collected at 
the end of the study (t= 120 min).
Blood samples for determination of plasma glucose, 
[6,6-2H 2]glucose enrichment, insulin, counter-regulatory 
hormones and cytokines were collected in pre-chilled 
heparinized tubes and samples for alanine and lactate 
into fluoride tubes. All samples were kept on ice and 
centrifuged promptly. Aliquots of separated plasma were 
stored below - 20°C and transported on dry ice before as­
say.
A  ssays
All measurements were performed in duplicate and all 
samples of each individual subject were analysed in the 
same run. Glucose concentration and [6,6- H2]glucose 
enrichment in plasma were measured by gas chromatog­
raphy/mass spectometry using selected ion monitoring. 
The method was adapted from that of R einauer  et al, 
(1990), using phenyl-(3-D-glucose as internal standard.
Plasma insulin concentration was measured by com­
mercial radioimmunoassay (RIA) (Pharmacia Diagnos­
tics, Uppsala, Sweden), glucagon by RIA (Daiichi Radio­
isotope Laboratories, Tokyo, Japan, using glucagon 
antiserum elicited in guinea-pigs against pancreatic spe­
cific glucagon; cross-reactivity with glucagon-like sub­
stances of intestinal origin less than 1%), catecholamines 
by high-performance liquid chromatography and elec­
trochemical detection, after purification on Biorex 70™ 
and concentration by solvent extraction (Smedes et aL3 
1982), and cortisol by fluorescence polarization immu­
noassay on TDx™ (Abbott Laboratories, Chicago, Illi­
nois, USA). Plasma alanine concentration was deter­
mined by amino acid analyser (Chromocon 500™, 
Kontron, Italy) and plasma lactate by an enzymatic 
method (Boehringer Mannheim, Almere, The Nether­
lands) on a Cobas Bio-Centrifugal™ analyser.
Tumour necrosis factor a  (TNF-a) concentrations 
were measured by enzyme amplified sensitivity assay 
( e a s ia ) (Medgenix, Amersfoort, The Netherlands) with 
a detection limit of 5 pg/mL. Souble TNF-receptors 
types I and II (sTNF-RI and sTNF-RII) were measured 
by EASIA, with detection limits of 0*1 and 0*5 ng/mL, re­
spectively. Plasma concentrations of interleukin (IL) 1 
were measured by immunoradiometric assay (Medgenix, 
Amersfoort, The Netherlands), detection limit 10 
pg/mL, and IL -6 was determined by an enzyme-linked 
immunosorbent assay (e l is a ) (CLB, Amsterdam, The 
Netherlands), detection level 2 pg/mL. Plasma concen­
trations of IL-10 were measured by ELISA (kindly pro­
vided by Schering-Plough Research Institute, Kenil­
worth, New Jersey, USA), detection limit 20 pg/mL.
Calculations and statistics
Glucose production rate was calculated from the dilu­
tion of the infused tracer in plasma. Because plasma glu­
cose concentrations and tracer/tracee ratios for [6 ,6- 
2H 2]glucose remained constant during the study, 
calculations for steady state kinetics were applied, 
adapted for the use of stable isotopes (WOLFE, 1992).
Data are reported as medians and ranges. A correla­
tion coefficient was calculated for plasma glucose con­
centrations and glucose production, using linear regres­
sion analysis to investigate the relationship. Statistical 
significance was set at P < 0*05.
Results
Clinical data
Twenty children (including 8 girls) with uncompli­
cated acute falciparum malaria were studied (Table 1). 
Their illness had a median duration of 3 d (range 1-6 d) 
and they had not fed for a median period of 12 h (range 
4-24 h) before the study. Median axillary temperature 
was 39-3°C (range 37*0-40*8°C). Albumin concentrations
Table 1. Physical, biochemical and parasitological 
characteristics o f 20 Kenyan children with uncompli- 
ated falciparum malaria
Median Range
Age (years) 4*5 2 0 - 10*0
Height (cm) 103 79-132
Weight (kg) 14*2 9*4-23*0
Plasma glucose (mmol/L) 4*5 2*1—6*5
Glucose production (mg/kg/min) 5*0 4* 1-8*4
Parasite count (per ¡iL) 205110 77-699200
Haemoglobin (g/dL) 9*4 6 *6—12*8
Serum albumin (g/L) 36 29-47
Serum AST3 (units/L) 32 24-92
Serum ALT (units/L) 12 6-29
Serum bilirubin (j.imol/L) 13 3-28
Aspartate aminotransferase. 
’Alanine aminotransferase.
were normal except in one child, who did not differ from 
the other subjects in terms of weight-for-height or 
height-for-age by the US National Center of Health Sta­
tistics standards (H a m il l  et al.y 1979). Using these 
standards 10 children were below the tenth percentile of 
weight-for-height and 12 were below the tenth percentile 
of height-for-age. All patients responded quickly to ther­
apy and made uneventful recoveries.
Glucose kinetics 
Plasma glucose concentrations at times i=90 min, 
i=105 min and r=120 min were similar. (Table 1). Al­
though one of the inclusion criteria was plasma glucose 
concentration >2*2 mmol/L, one patient developed a 
plasma glucose level of 2T mmol/L during the study. 
The individual plasma glucose concentrations, includ­
ing the low values, were also constant during the time of 
the study.
Isotopic steady state was obtained because there was 
no difference in tracer/tracee ratios between £=90 min, 
f=105 min and /=120 min (data not shown). There was 
a positive correlation between plasma glucose concentra­
tion and basal glucose production ( t - 0-53, P=0*016) 
(Figure).
No correlation was found between age, parasite count 
or body temperature, duration of fasting or duration of 
illness at the start of the study and plasma glucose con­
centration or the rate of glucose production.
Hormones, precursors and cytokines
Plasma concentrations of insulin and glucose counter-
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Figure. The relationship between the rate of hepatic glucose 
production and plasma glucose concentration in 20 Kenyan 
children with uncomplicated falciparum malaria (r=0*53,
P=0*016).
656 EVELIEN DEKKER ETAL.
Table 2. Plasma concentrations of insulin, counter- 
regulatory hormones, gluconeogenic precursors and 
cytokines in 20 Kenyan children with uncomplicated 
falciparum malaria
Patients3
N orm al 
fasting 
range
Insulin (milliunits/L) 4(1-25) 5-25
Cortisol (jumol/L) 0-62 (0-14-2-27) 0*22-0*65
Glucagon (ng/L) 165 (45-498) 40-140
Noradrenaline (nmol/L) 1T8 (0-45-3 *90) <3*25
Adrenaline (nmol/L) 0*60 (0-15-1-98) <0*55
Alanine (|imoI/L) 132 (74-290) 158-314
Lactate (mmol/L) 1-3 (0*8-27) 0 -6- 2-0
TNF-a (pg/mL) 135 (18-468) < 2 0
sTNF-RI (ng/mL) 6*4 (2-1-147) 0'3-2*9
sTNF-RII (ng/mL) 44*4 (12-6-121*0) 1*9-8-5
IL-1 (pg/mL) < 1 0  ( < 10) < 1 0
IL -6 (pg/mL) 47 (6-342) < 10
IL-10 (pg/mL 605 (185-3215) < 2 0
aMedian (range in parentheses). Abbreviations: T N F=tum our 
necrosis factor, sTNF-RI and sTNF-RII —soluble TNF recep­
tors, IL=interleukin.
regulatory hormones, alanine and lactate are shown in 
Table 2. Plasma insulin concentrations were appropri­
ately low and plasma concentrations of the counter-regu­
latory hormones were appropriately high in all children, 
with 2 exceptions. One child had a plasma insulin con­
centration of 25 milliunits/L; glucose production in this 
child was 5-4 mg/kg/min. Another child had a low 
plasma cortisol concentration (0*14 ¡amol/L), and a glu­
cose production rate of 4’5 mg/kg/min. These values for 
glucose production were both intermediate in our study 
group. The plasma concentrations of the other gluco- 
regulatory hormones in these 2 children were appropri­
ate.
Plasma alanine concentrations were slightly low and 
plasma lactate concentrations were normal.
There was no correlation between the rate of glucose 
production and plasma concentrations of insulin or the 
counter-regulatory hormones, or between glucose pro­
duction and plasma concentrations of the gluconeogenic 
precursors alanine and lactate (either separately or com­
bined).
Plasma concentrations of the cytokines TNF-a, 
sTNF-RI and RIÏ, IL-1, IL-6 and IL-10 are also shown 
in Table 2. There was no correlation between any of 
these cytokines and the rate of glucose production.
Discussion
This was the first study of glucose production in chil­
dren with falciparum malaria. The children we studied 
required hospital admission, but had no defining feature 
of severe malaria (WHO, 1986). They were thus interme­
diate between mild out-patient malaria cases and those 
with the highest risk of hypoglycaemia. In these chil­
dren there was a positive correlation between plasma 
glucose concentration and basal glucose production, in­
dicating that children with the lowest plasma glucose 
concentration had the lowest glucose production rates. 
Our data suggested that plasma glucose concentrations 
are primarily determined by glucose production in chil­
dren with uncomplicated falciparum malaria.
The clinical data indicated that the Kenyan children 
evaluated in this study had a weight-for-height and 
height-for-age around the tenth percentile of the US 
standards (H am ill et a l ,  1979). None the less, physical 
examination indicated that the children were well pro­
portioned and had no other underlying disease; their 
plasma albumin concentrations supported this finding. 
Hence, stunted growth in the past and not malnourish- 
ment at the time of the study was the most probable ex­
planation for the low anthropometric values,
The declaration of Helsinki, serving as a guideline for 
clinical research, does not allow invasive studies in 
healthy children. We were therefore unable to obtain 
data from healthy Kenyan children for comparison with 
our patients. Studies in convalescence were inappropri­
ate, for the same reason. There are only 2 published 
studies on basal glucose production measured by means 
of a non-recycling isotope in healthy children of the 
same age group elsewhere in the world (B ier  et a l 3 1977; 
H a y m o n D et a l , 1978). Basal glucose production was, on 
average, approximately 30% lower in the Kenyan chil­
dren in our study than in healthy American children 
with similar body weight (BIER et al., 1977). The present 
study suggested that, contrary to the findings in adults, 
glucose production in children with uncomplicated fal­
ciparum malaria is not increased. Although the compari­
son with healthy American children may not be optimal, 
this does not invalidate our observation of a positive cor­
relation between plasma glucose concentration and glu­
cose production in children with malaria.
It is unlikely that the duration of fasting was a deci­
sive factor in our study, as the mean duration was only 
12 h and literature data suggest that only prolonged fast­
ing ( > 1  d) is a factor contributing to hypoglycaemia in 
children with falciparum malaria (TAYLOR et al> 1988; 
K a w o  et a l 3 1990). Moreover, there was no correlation 
between the duration of fasting and plasma glucose con­
centration or glucose production.
The only antimalarial drug known to influence glu­
cose metabolism is quinine, which stimulates insulin re­
lease (HENQUIN et a l ,  1975; WHITE et a l , 1983; DAVIS et 
a l 9 1990). This was not a confounding variable in our 
study, as none of the children had detectable plasma qui­
nine concentrations and plasma insulin concentrations 
were appropriately low.
Theoretically, cytokines and/or counter-regulatory 
hormones could be implicated in the regulation of glu­
cose production in our children with malaria as it is well 
recognized that catecholamines, glucagon and relatively 
low levels of the cytokines TNF-a and IL-6 can stimu­
late glucose production in humans (SHAMOON et ah,
1981; G e l fa n d  et a l , 1984; VAN d e r  P o l l  et a l , 1991; 
St o u t h a r d  et a l y 1995), whereas IL -1 induces hypogly­
caemia in animal models (F isc h e r  et al .0 1991). As TNF- 
a  is secreted episodically and the concentrations of sol­
uble TNF receptors in plasma are considered to be 
better markers of TNF activity (G o d f r ie d , 1994), we 
also included the plasma concentrations of soluble TNF 
receptors in our analysis. A significant stimulation of 
counter-regulatory hormone and cytokine production 
was found in our patients, in accordance with other re­
ports in malaria (KERN e ta l ,  1989, 1992; KWIATKOWSKI
et al., 1990; P h il l ip s  et a l , 1993; P ey ro n  et a/., 1994).
However, no correlation was found between the rate of 
glucose production and the plasma concentrations of 
these substances, separately or combined, suggesting 
that neither of them could be implicated as a major de­
terminant for glucose production in these children with 
uncomplicated malaria.
In untreated malaria, glucose metabolism is deter­
mined by factors related to host and parasite, and it has 
been suggested that a large glucose requirement by the 
parasite may contribute to the induction of hypoglycae­
mia (W h it e  et al., 1983). Although some contribution 
seems plausible, the direct role of the parasite appears to 
be limited. It can be calculated from data obtained from 
growth studies in vitro on Plasmodium falciparum para­
sites (ZoLG et a l , 1984) that, in severe infections, the 
parasite consumes at the most 10% of total glucose pro­
duction, suggesting that changes in the host are the most 
important precipitating factors for hypoglycaemia. 
Moreover, if increased peripheral use of glucose were a 
decisive factor in determining glucose concentration in 
malaria, a negative correlation would be expected be­
tween the rate of glucose production and the plasma glu­
cose concentration. In contrast, we found a positive cor­
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relation between glucose production and glucose con­
centration. Therefore, a major effect on glucose concen­
tration by the parasite seems improbable in our patients.
In adults with severe falciparum malaria there is an 
inverse correlation between plasma glucose concentra­
tion and glucose production (D avis et a l , 1993), suggest- 
ing that facilitated peripheral glucose uptake rather than 
decreased production was the most important determi­
nant for glucose concentration. In contrast, in children 
with uncomplicated falciparum malaria there was a posi­
tive correlation between glucose production and glucose 
concentration, suggesting that the rate of production of 
glucose rather than glucose uptake was the most impor­
tant determinant of plasma glucose concentration. These 
data suggest that glucose metabolism in falciparum ma­
laria is differently regulated in children and adults.
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